Editorial: improving the use of Montreal classification through a bidirectional approach
- PMID: 37307547
- DOI: 10.1111/apt.17529
Editorial: improving the use of Montreal classification through a bidirectional approach
Comment on
-
Evaluation of a downstaging, bidirectional version of the Montreal classification of Crohn's disease: Analysis of 5-year follow-up data from the prospective BioCrohn study.Aliment Pharmacol Ther. 2023 Jul;58(1):35-47. doi: 10.1111/apt.17512. Epub 2023 Apr 13. Aliment Pharmacol Ther. 2023. PMID: 37051808
References
-
- Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress Of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A-36A. https://doi.org/10.1155/2005/269076
-
- Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Helwig U, Teich N, Schmidt C, et al. Evaluation of downstaging, bidirectional version of Montreal classification of Crohn's disease: analysis of 5-year follow-up data from the prospective BioCrohn study. Aliment Pharmacol Ther. 2023;58:35-47.https://doi.org/10.1111/apt.17512
-
- Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010;105(2):289-97. https://doi.org/10.1038/ajg.2009.579
-
- Tarrant KM, Barclay ML, Frampton CMA, Gearry RB. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008;103(12):3082-93. https://doi.org/10.1111/j.1572-0241.2008.02212.x